Advent International proposed buying Definitive Healthcare’s outstanding Class A common stock and OpCo units not already owned by Advent or Jason Krantz for $1.02 each in cash. The non-binding offer requires Special Committee review, and investors have no action to take while the company evaluates its response.
Key Highlights
- Definitive Healthcare’s Special Committee consists entirely of disinterested and independent directors.
- Advent’s proposal covers Equity interests not already owned by Advent or founder Jason Krantz.
- Rothschild & Co and Skadden, Arps, Slate, Meagher & Flom are advising the Special Committee.
Definitive Healthcare Corp. (NASDAQ: DH) is weighing a non-binding all-cash offer from Advent International to buy eligible outstanding equity for $1.02 per share. The proposal covers Class A common stock and equivalent interests in AIDH TopCo, LLC that are not already held by Advent or Jason Krantz.
Advent Proposal Covers Remaining Equity
The indication of interest is dated Sept. 1 and was made on behalf of certain Advent-managed funds. It seeks all outstanding Class A common stock excluded from Advent’s and Krantz’s existing ownership, along with the remaining Limited Liability company interests known as Definitive OpCo Units. The cash consideration is $1.02 for each Class A share and the same amount for each Definitive OpCo Unit. The Special Committee was established to consider a potential transaction with Advent or an alternative outcome. Rothschild & Co is its financial adviser, while Skadden, Arps, Slate, Meagher & Flom LLP is providing legal advice. Evercore (NYSE: EVR) is advising Definitive Healthcare, with Hogan Lovells Cadwalader serving as legal counsel.
Independent Committee Keeps Decision Pending
The committee is made up entirely of independent, disinterested directors and will assess the proposal with its advisers before deciding what course it believes serves the interests of Definitive Healthcare and its stockholders. No stockholder action is required at this stage. The proposal remains non-binding. Definitive Healthcare cautioned that it may not pursue the transaction or another strategic outcome, and that any deal may not receive approval or close.
Peers Moving on This News
- Health Catalyst, Inc (NASDAQ: HCAT) down 0.6%
- OptimizeRx Corporation (NASDAQ: OPRX) up 1.6%
- LifeMD, Inc. (NASDAQ: LFMD) down 0.3%



Please wait processing your request...